Q1 25 EPS
$1.23
BEAT +3.53%
Est. $1.19
Q1 25 Revenue
$5.26B
BEAT +13.95%
Est. $4.62B
vs S&P Since Q1 25
+2.2%
BEATING MARKET
MO +32.2% vs S&P +30.0%
Market Reaction
Did MO Beat Earnings? Q1 2025 Results
Altria Group delivered a stronger-than-expected first quarter, with adjusted diluted EPS of $1.23 clearing the $1.19 consensus estimate by 3.53%, while revenue of $5.26 billion ran 13.95% ahead of the $4.62 billion Wall Street expected and grew 11.5%… Read more Altria Group delivered a stronger-than-expected first quarter, with adjusted diluted EPS of $1.23 clearing the $1.19 consensus estimate by 3.53%, while revenue of $5.26 billion ran 13.95% ahead of the $4.62 billion Wall Street expected and grew 11.5% year-over-year, a result that underscores the resilience of the tobacco giant's pricing power even as cigarette volumes erode. The headline story, however, carried a significant asterisk: an $873 million non-cash goodwill impairment tied to its NJOY e-vapor unit, triggered by an ITC importation ban on NJOY ACE products taking effect March 31, dragged reported diluted EPS down 47.9% to $0.63, masking otherwise steady underlying progress. Adjusted smokeable segment income grew 2.7% despite domestic cigarette shipment volume falling 13.7%, while on! Nicotine pouch shipments surged 18.0%, reflecting the accelerating structural shift toward smoke-free alternatives. Altria's dividend standing remained intact as the company reaffirmed full-year 2025 adjusted EPS guidance of $5.30 to $5.45, representing 2% to 5% growth, even as it assumes ACE does not return to market this year.
Key Takeaways
- • Higher pricing in smokeable products offset lower shipment volume
- • Lower per unit settlement charges in smokeable products
- • Fewer shares outstanding drove adjusted EPS growth
- • Lower adjusted tax rate (23.5% vs 24.6% prior year)
- • on! nicotine pouches shipment volume grew 18.0% with retail share up 1.8 points to 8.8%
- • NJOY consumables shipment volume grew 23.9% to 13.5 million units
- • Smokeable products adjusted OCI margins expanded 4.2 percentage points to 64.4%
MO YoY Financials
Q1 2025 vs Q1 2024, source: SEC Filings
MO Revenue by Segment
With YoY comparisons, source: SEC Filings
“Our highly profitable traditional tobacco businesses performed well in a challenging environment in the first quarter. The smokeable products segment delivered solid adjusted operating companies income growth behind the strength of Marlboro. In the oral tobacco products segment, on! maintained momentum in a competitive marketplace as Helix invested strategically behind the brand. And shareholders continued to benefit from strong cash returns through dividends and share repurchases, while we invested in pursuit of our Vision.”
— Billy Gifford, Q1 2025 Earnings Press Release
MO Earnings Trends
MO vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
MO EPS Trend
Earnings per share: estimate vs actual
MO Revenue Trend
Quarterly revenue: estimate vs actual
MO Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 | — | $1.32 | — | $5.43B | +18.58% |
| Q4 25 BEAT FY | $1.25 | $1.30 | +4.39% | $5.85B | +27.85% |
| FY Full Year | — | $5.42 | — | $23.28B | — |
| Q3 25 BEAT | $1.45 | $1.45 | +0.12% | $5.25B | -1.05% |
| Q2 25 BEAT | $1.38 | $1.44 | +3.99% | $5.29B | +1.94% |
| Q1 25 BEAT | $1.19 | $1.23 | +3.53% | $5.26B | +13.95% |